Stage IV Colorectal Cancer Recruiting Phase 1 / 2 Trials for Irinotecan (DB00762)

IndicationStatusPhase
DBCOND0042053 (Stage IV Colorectal Cancer)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03368963TAS102 in Combination With NAL-IRI in Advanced GI CancersTreatment